Shannon Sullivan
Publication Details
-
Emerging drugs for insomnia: new frontiers for old and novel targets.
Expert Opin Emerg Drugs. 2009; (3): 411-22
Insomnia is the most prevalent sleep disorder, with up to 50% of the US adult population reporting symptoms of insomnia on a weekly basis and approximately 12% with insomnia disorder. Comorbid conditions such as depression and anxiety are frequent. Insomnia is more common with older age, female gender and socioeconomic status. Traditionally, therapy has focused on GABA(A) receptor agonists, and off-label antidepressant and antihistamine use.
Help